Aptar Pharma teams up with COVIRIX Medical to explore next-generation antiviral inhaler
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Launches advanced bone density systems in India & Dubai
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
DiaMedica said it plans to launch the trial later in 2026
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
The new patents cover critical advancements in cochlear implant technology
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
Subscribe To Our Newsletter & Stay Updated